FDA sets December approval decision for first CRISPR therapy, with 94% of patients free of sickle cell crises

FDA sets December approval decision for first CRISPR therapy, with 94% of patients free of sickle cell crises

Upworthy

Published

Near­ly 11 years ago, sci­en­tists pro­grammed a pair of mol­e­c­u­lar scis­sors to make pre­cise cuts in DNA. That first test tube ex­per­i­ment of CRISPR gene edit­ing tech­nol­o­gy won its cre­ators a No­bel Prize, ig­nit­ed a gene edit­ing rev­o­lu­tion in life sci­ence labs, and kick-start­ed…

#crispr #medicines #finish #fda #unlock

Full Article